Aurinia Pharmaceuticals
AUPH • NASDAQ
Aurinia Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Kevin C. Tang, with a market cap of $1.9B.
Market Cap$1.9B
Employees300.0
CEOKevin C. Tang
CountryCanada
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Aurinia Pharmaceuticals FAQ
Common questions about Aurinia Pharmaceuticals
Aurinia Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $77.1M.
Aurinia Pharmaceuticals has approximately 300 employees.